Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetes.
Jenkins AJ, Januszewski AS, Kirby A, Hendrieckx C, McAuley SA, Lee MH, Paldus B, Vogrin S, de Bock MI, Abraham MB, Bach LA, Burt MG, Cohen ND, Colman PG, Davis EA, Holmes-Walker DJ, Kaye J, Keech AC, Kumareswaran K, MacIsaac RJ, McCallum RW, Sims CM, Speight J, Stranks SN, Sundararajan V, Trawley S, Ward GM, Jones TW, O'Neal DN; Australian JDRF Closed Loop Research Group. Jenkins AJ, et al. Among authors: de bock mi. Intern Med J. 2025 Jan;55(1):148-153. doi: 10.1111/imj.16567. Epub 2024 Nov 27. Intern Med J. 2025. PMID: 39601386
Automated Insulin Delivery for Young People with Type 1 Diabetes and Elevated A1c.
Boucsein A, Zhou Y, Michaels V, Haszard JJ, Jefferies C, Wiltshire E, Paul RG, Parry-Strong A, Pasha M, Petrovski G, de Bock MI, Wheeler BJ. Boucsein A, et al. Among authors: de bock mi. NEJM Evid. 2024 Oct;3(10):EVIDoa2400185. doi: 10.1056/EVIDoa2400185. Epub 2024 Sep 24. NEJM Evid. 2024. PMID: 39315863 Clinical Trial.
Protocol for a prospective, multicenter, parallel-group, open-label randomized controlled trial comparing standard care with Closed lOoP In chiLdren and yOuth with Type 1 diabetes and high-risk glycemic control: the CO-PILOT trial.
Boucsein A, Zhou Y, Haszard JJ, Jefferies CA, Wiltshire EJ, Styles SE, Crocket HR, Galland BC, Pasha M, Petrovski G, Paul RG, de Bock MI, Wheeler BJ. Boucsein A, et al. Among authors: de bock mi. J Diabetes Metab Disord. 2024 Mar 7;23(1):1397-1407. doi: 10.1007/s40200-024-01397-4. eCollection 2024 Jun. J Diabetes Metab Disord. 2024. PMID: 38932805 Free PMC article.
Acceptability and experiences of real-time continuous glucose monitoring in adults with type 2 diabetes using insulin: a qualitative study.
Sergel-Stringer OT, Wheeler BJ, Styles SE, Boucsein A, Lever CS, Paul RG, Sampson R, Watson A, de Bock MI. Sergel-Stringer OT, et al. Among authors: de bock mi. J Diabetes Metab Disord. 2024 Mar 5;23(1):1163-1171. doi: 10.1007/s40200-024-01403-9. eCollection 2024 Jun. J Diabetes Metab Disord. 2024. PMID: 38932793 Free PMC article.
Improved Glycemic Outcomes With Diabetes Technology Use Independent of Socioeconomic Status in Youth With Type 1 Diabetes.
Lomax KE, Taplin CE, Abraham MB, Smith GJ, Haynes A, Zomer E, Ellis KL, Clapin H, Zoungas S, Jenkins AJ, Harrington J, de Bock MI, Jones TW, Davis EA; Australasian Diabetes Data Network (ADDN) Study Group. Lomax KE, et al. Among authors: de bock mi. Diabetes Care. 2024 Apr 1;47(4):707-711. doi: 10.2337/dc23-2033. Diabetes Care. 2024. PMID: 38324670
Study protocol: glycaemic outcomes in people with type 2 diabetes initiating continuous glucose monitoring: the 2GO-CGM study.
Lever CS, Williman JA, Boucsein A, Watson A, Sampson RS, Sergel-Stringer OT, Keesing C, Chepulis L, Wheeler BJ, de Bock MI, Paul RG. Lever CS, et al. Among authors: de bock mi. J Diabetes Metab Disord. 2023 Jun 15;22(2):1779-1792. doi: 10.1007/s40200-023-01244-y. eCollection 2023 Dec. J Diabetes Metab Disord. 2023. PMID: 37969919 Free PMC article.
44 results